Applied Molecular Transport. has filed a patent for delivery constructs involving carriers coupled to payloads for transporting therapeutic payloads across epithelial cells. The method includes administering a carrier-payload complex derived from a Cholix polypeptide with a leucine at position 1 to treat inflammatory or autoimmune diseases. GlobalData’s report on Applied Molecular Transport gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Applied Molecular Transport Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Applied Molecular Transport, Genetic engineered chimeric antibodies was a key innovation area identified from patents. Applied Molecular Transport's grant share as of January 2024 was 47%. Grant share is based on the ratio of number of grants to total number of patents.

Oral delivery of therapeutic payload using carrier-payload complex

Source: United States Patent and Trademark Office (USPTO). Credit: Applied Molecular Transport Inc

A recently filed patent (Publication Number: US20240009316A1) describes a method involving the administration of a carrier-payload complex to a subject. The complex consists of a carrier derived from a Cholix polypeptide with a specific leucine at position 1, coupled with a heterologous payload. This method aims to deliver the payload effectively to the subject for potential therapeutic or diagnostic purposes.

The use of a carrier derived from a Cholix polypeptide with a specific leucine at position 1, combined with a heterologous payload, is a key aspect of the patented method. By administering this carrier-payload complex to a subject, the patent aims to achieve efficient delivery of the payload. This innovative approach may have implications for various fields, including medicine, biotechnology, and drug delivery systems. Further research and development based on this patented method could lead to advancements in targeted drug delivery and personalized medicine.

To know more about GlobalData’s detailed insights on Applied Molecular Transport, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies